[1] BRAY F,LAVERSANNE M,SUNG H,et al.Global cancer statistics 2022:Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].CA Cancer J Clin,2024,74(3):229-263.
[2] LUOND F,TIEDE S,CHRISTOFORI G,et al.Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression [J].Br J Cancer,2021,125(2):164-175.
[3] KAWIAK A.Molecular research and treatment of breast cancer [J].Int J Mol Sci,2022,23(17):1509-1528.
[4] ARYA SB,COLLIE SP,PARENT CA,et al.The ins-and-outs of exosome biogenesis,secretion,and internalization [J].Trends Cell Biol,2024,34(2):90-108.
[5] SINGH S,PAUL D,NATH V,et al.Exosomes:Current knowledge and future perspectives[J].Tissue Barriers,2024,12(2):2232248-2232266.
[6] LEHMANN TP,GOLIK M,OLEJNIK J,et al.Potential applications of using tissue-specific Evs in targeted therapy and vaccinology [J].Biomed Pharmacother,2023,166:115308-115321.
[7] SHETA M,TAHA EA,LU Y,et al.Extracellular vesicles:New classification and tumor immunosuppression [J].Biology (Basel),2023,12(1):1026-1039.
[8] LEE Y,NI J,BERETOV J,et al.Recent advances of small extracellular vesicle biomarkers in breast cancer diagnosis and prognosis [J].Mol Cancer,2023,22(1):33-45.
[9] LIU WZ,MA ZJ,KANG XW,et al.Current status and outlook of advances in exosome isolation [J].Anal Bioanal Chem,2022,414(24):7123-7141.
[10] OZAWA PMM,JUCOSKI TS,VIEIRA E,et al.Liquid biopsy for breast cancer using extracellular vesicles and cell-free micrornas as biomarkers [J].Transl Res,2020,223(2):40-60.
[11] SAMUELS M,JONES W,TOWLER B,et al.The role of non-coding rnas in extracellular vesicles in breast cancer and their diagnostic implications [J].Oncogene,2023,42(41):3017-3034.
[12] THAKUR C,QIU Y,PAWAR A,et al.Epigenetic regulation of breast cancer metastasis [J].Cancer Metastasis Rev,2024,43(2):597-619.
[13] KATSURA C,OGUNMWONYI I,KANKAM HK,et al.Breast cancer:presentation,investigation and management [J].Br J Hosp Med (Lond),2022,83(2):1-7.
[14] KHAN MM,YALAMARTY SSK,RAJMALANI BA,et al.Recent strategies to overcome breast cancer resistance [J].Crit Rev Oncol Hematol,2024,197:104351.
[15] BHAN A,SOLEIMANI M,MANDAL SS,et al.Long noncoding RNA and cancer:A new paradigm [J].Cancer Res,2017,77(15):3965-3981.
[16] HERMAN AB,TSITSIPATIS D,GOROSPE M,et al.Integrated LncRNA function upon genomic and epigenomic regulation [J].Mol Cell,2022,82(12):2252-2266.
[17] KONG X,DUAN Y,SANG Y,et al.LncRNA-Cdc6 promotes breast cancer progression and function as cerna to target cdc6 by sponging MicroRNA-215 [J].J Cell Physiol,2019,234(6):9105-9117.
[18] XU Y,ZHU H,MA H,et al.Linc01305 inhibits malignant progression of cervical cancer via miR-129-5p/Sox4 axis [J].Am J Transl Res,2020,12(11):7581-7592.
[19] XIONG L,TAN J,ZHANG R,et al.Linc01305 recruits basonuclin 1 to act on G-protein pathway suppressor 1 to promote esophageal squamous cell carcinoma [J].Cancer Sci,2023,114(11):4314-4328.
[20] HUANG GW,CHEN QQ,MA CC,et al.Linc01305 promotes metastasis and proliferation of esophageal squamous cell carcinoma through interacting with Igf2bp2 and Igf2bp3 to Stabilize Htr3a mRNA [J].Int J Biochem Cell Biol,2021,136:106015-106030.
[21] HUANG X,LIU X,DU B,et al.LncRNA Linc01305 promotes cervical cancer progression through khsrp and exosome-mediated transfer [J].Aging (Albany NY),2021,13(15):19230-19242.
[22] LI SR,MAN QW,GAO X,et al.Tissue-derived extracellular vesicles in cancers and non-cancer diseases:present and future [J].J Extracell Vesicles,2021,10(14):e12175-12199.